Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Hyperthermia 1Colonic Neoplasms 1Cholangiocarcinoma 1Breast Neoplasms 1

Interventions

Specimen Handling 200Magnetic Resonance Spectroscopy 160pembrolizumab 153Carboplatin 117Biopsy 108Cyclophosphamide 100Cisplatin 91Paclitaxel 78Gemcitabine 67Bevacizumab 66Nivolumab 59fludarabine 57Radiotherapy 54Fluorouracil 52Dexamethasone 47Capecitabine 46Oxaliplatin 45Doxorubicin 44Docetaxel 44Pemetrexed 43Rituximab 42Leucovorin 42venetoclax 40durvalumab 38atezolizumab 36Radiation 36Standard of Care 34Prednisone 33Injections 32Cetuximab 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Diathermy × 30 days × Clear all
NCT07224464 2026-05-15

The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.

New Phase Ltd.

Phase NA Recruiting
12 enrolled
BreastGastrointestinalGynecologicThoracic

Hyperthermia, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡